NUCLEASE THERAPEUTICS IN THE CLINIC

被引：2

作者：

EDGINGTON, SM

机构：

来源：

BIO-TECHNOLOGY | 1993年 / 11卷 / 05期

关键词：

D O I：

10.1038/nbt0593-580

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：580 / 582

页数：3

共 5 条

[1] RECOMBINANT HUMAN DNASE INHALATION IN NORMAL SUBJECTS AND PATIENTS WITH CYSTIC-FIBROSIS - A PHASE-1 STUDY [J].

AITKEN, ML ;

BURKE, W ;

MCDONALD, G ;

SHAK, S ;

MONTGOMERY, AB ;

SMITH, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (14) :1947-1951

[2]

CHERNICK WS, 1959, PEDIATRICS, V24, P739

[3] A PRELIMINARY-STUDY OF AEROSOLIZED RECOMBINANT HUMAN DEOXYRIBONUCLEASE-I IN THE TREATMENT OF CYSTIC-FIBROSIS [J].

HUBBARD, RC ;

MCELVANEY, NG ;

BIRRER, P ;

SHAK, S ;

ROBINSON, WW ;

JOLLEY, C ;

WU, M ;

CHERNICK, MS ;

CRYSTAL, RG .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12) :812-815

[4]

LIAO TH, 1973, J BIOL CHEM, V248, P1489

[5] RECOMBINANT HUMAN DNASE-I REDUCES THE VISCOSITY OF CYSTIC-FIBROSIS SPUTUM [J].

SHAK, S ;

CAPON, DJ ;

HELLMISS, R ;

MARSTERS, SA ;

BAKER, CL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9188-9192

← 1 →